Amerisure Pharmaceuticals L L C is categorized under Wholesale Pharmaceutical Products in Silver Spring, MD and active since 2008.
Amerisure Pharmaceuticals L L C was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Mackie Barch at the company’s single location by writing to 9337 Fraser Avenue, Silver Spring, Maryland MD 20910 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Amerisure Pharmaceuticals L L C |
Contact Person: | Mackie Barch |
Address: | 9337 Fraser Avenue, Silver Spring, Maryland 20910 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Amerisure Pharmaceuticals L L C was started in 2008 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Mackie Barch for inquiries that concern Amerisure Pharmaceuticals L L C by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Amerisure Pharmaceuticals L L C can be found at the coordinates 39.009127,-77.050739 as well as the street address 9337 Fraser Avenue in Silver Spring, Maryland 20910.
For its online presence, you may visit Amerisure Pharmaceuticals L L C’s website at and engage with its social media outlets through on Twitter and on Facebook.